These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 16403733)
1. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. Albini A; Dell'Eva R; Vené R; Ferrari N; Buhler DR; Noonan DM; Fassina G FASEB J; 2006 Mar; 20(3):527-9. PubMed ID: 16403733 [TBL] [Abstract][Full Text] [Related]
3. AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Dell'Eva R; Ambrosini C; Vannini N; Piaggio G; Albini A; Ferrari N Cancer; 2007 Nov; 110(9):2007-11. PubMed ID: 17823911 [TBL] [Abstract][Full Text] [Related]
4. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy. Singh RP; Dhanalakshmi S; Agarwal C; Agarwal R Oncogene; 2005 Feb; 24(7):1188-202. PubMed ID: 15558015 [TBL] [Abstract][Full Text] [Related]
5. The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration. Benelli R; Venè R; Ciarlo M; Carlone S; Barbieri O; Ferrari N Biochem Pharmacol; 2012 Jun; 83(12):1634-42. PubMed ID: 22445931 [TBL] [Abstract][Full Text] [Related]
6. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Colgate EC; Miranda CL; Stevens JF; Bray TM; Ho E Cancer Lett; 2007 Feb; 246(1-2):201-9. PubMed ID: 16563612 [TBL] [Abstract][Full Text] [Related]
7. The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway. Dell'Eva R; Ambrosini C; Minghelli S; Noonan DM; Albini A; Ferrari N Carcinogenesis; 2007 Feb; 28(2):404-13. PubMed ID: 16952909 [TBL] [Abstract][Full Text] [Related]
8. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Maffucci T; Piccolo E; Cumashi A; Iezzi M; Riley AM; Saiardi A; Godage HY; Rossi C; Broggini M; Iacobelli S; Potter BV; Innocenti P; Falasca M Cancer Res; 2005 Sep; 65(18):8339-49. PubMed ID: 16166311 [TBL] [Abstract][Full Text] [Related]
10. Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Vanhoecke B; Derycke L; Van Marck V; Depypere H; De Keukeleire D; Bracke M Int J Cancer; 2005 Dec; 117(6):889-95. PubMed ID: 15986430 [TBL] [Abstract][Full Text] [Related]
11. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589. Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Kaposi's sarcoma in vivo by fenretinide. Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues. Nuti E; Bassani B; Camodeca C; Rosalia L; Cantelmo A; Gallo C; Baci D; Bruno A; Orlandini E; Nencetti S; Noonan DM; Albini A; Rossello A Eur J Med Chem; 2017 Sep; 138():890-899. PubMed ID: 28750311 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB. Gao X; Deeb D; Liu Y; Gautam S; Dulchavsky SA; Gautam SC Immunopharmacol Immunotoxicol; 2009; 31(3):477-84. PubMed ID: 19555200 [TBL] [Abstract][Full Text] [Related]
15. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect. Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043 [TBL] [Abstract][Full Text] [Related]
16. Xanthohumol from the hop plant stimulates osteoblast differentiation by RUNX2 activation. Jeong HM; Han EH; Jin YH; Choi YH; Lee KY; Jeong HG Biochem Biophys Res Commun; 2011 May; 409(1):82-9. PubMed ID: 21565172 [TBL] [Abstract][Full Text] [Related]
17. Xanthohumol, a prenylated chalcone from beer hops, acts as an α-glucosidase inhibitor in vitro. Liu M; Yin H; Liu G; Dong J; Qian Z; Miao J J Agric Food Chem; 2014 Jun; 62(24):5548-54. PubMed ID: 24897556 [TBL] [Abstract][Full Text] [Related]
18. Enhanced effects of xanthohumol plus honokiol on apoptosis in 3T3-L1 adipocytes. Yang JY; Della-Fera MA; Rayalam S; Baile CA Obesity (Silver Spring); 2008 Jun; 16(6):1232-8. PubMed ID: 18369342 [TBL] [Abstract][Full Text] [Related]
19. miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion. Ho KH; Chang CK; Chen PH; Wang YJ; Chang WC; Chen KC J Neurochem; 2018 Aug; 146(3):269-288. PubMed ID: 29747239 [TBL] [Abstract][Full Text] [Related]
20. Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Gerhauser C; Alt A; Heiss E; Gamal-Eldeen A; Klimo K; Knauft J; Neumann I; Scherf HR; Frank N; Bartsch H; Becker H Mol Cancer Ther; 2002 Sep; 1(11):959-69. PubMed ID: 12481418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]